Charles Schwab Investment Management Inc G1 Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$2.2 - $4.98 $256,091 - $579,696	116,405 Added 541.02%	137,921 $314,000
Q3 2023 Nov 08, 2023	SELL	$1.22 - $2.67 $266,073 - $582,308	-218,093 Reduced 91.02%	21,516 $30,000
Q2 2023 Aug 09, 2023	BUY	$2.46 - $3.14 $86,702 - $110,669	35,245 Added 17.25%	239,609 $596,000
Q1 2023 May 11, 2023	BUY	$2.57 - $8.16 $54,602 - $173,367	21,246 Added 11.6%	204,364 $547,000
Q4 2022 Feb 13, 2023	BUY	$5.19 - $13.5 $11,558 - $30,064	2,227 Added 1.23%	183,118 $994,000
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $132,227 - $434,536	25,576 Added 16.47%	180,891 $2.26 Million
Q2 2022 Aug 15, 2022	SELL	$4.04 - $8.51 $448,561 - $944,865	-111,030 Reduced 41.69%	155,315 $768,000
Q1 2022 May 13, 2022	BUY	$7.6 - $11.02 $42,894 - $62,196	5,644 Added 2.16%	266,345 $2.03 Million
Q4 2021 Feb 11, 2022	BUY	$10.16 - $16.17 $208,970 - $332,584	20,568 Added 8.57%	260,701 $2.66 Million
Q3 2021 Nov 16, 2021	BUY	$13.16 - $22.47 $4,329 - $7,392	329 Added 0.14%	240,133 $3.22 Million
Q2 2021 Aug 16, 2021	BUY	$19.57 - $26.32 $255,466 - $343,581	13,054 Added 5.76%	239,804 $5.26 Million
Q1 2021 May 17, 2021	BUY	$17.58 - $32.59 $443,578 - $822,310	25,232 Added 12.52%	226,750 $5.46 Million
Q4 2020 Feb 16, 2021	BUY	$10.99 - $20.4 $5,703 - $10,587	519 Added 0.26%	201,518 $3.63 Million
Q3 2020 Nov 13, 2020	BUY	$11.55 - $23.75 $16,863 - $34,675	1,460 Added 0.73%	200,999 $2.32 Million
Q2 2020 Aug 14, 2020	BUY	$9.57 - $24.37 $125,185 - $318,783	13,081 Added 7.02%	199,539 $4.84 Million
Q1 2020 May 15, 2020	BUY	$9.07 - $26.32 $32,452 - $94,172	3,578 Added 1.96%	186,458 $2.06 Million
Q4 2019 Feb 07, 2020	BUY	$20.54 - $31.0 $64,516 - $97,371	3,141 Added 1.75%	182,880 $4.83 Million
Q3 2019 Nov 08, 2019	BUY	$22.78 - $40.58 $303,179 - $540,079	13,309 Added 8.0%	179,739 $4.1 Million
Q2 2019 Aug 09, 2019	BUY	$16.03 - $31.1 $418,046 - $811,056	26,079 Added 18.58%	166,430 $5.1 Million
Q1 2019 May 14, 2019	BUY	$14.4 - $21.45 $77,630 - $115,636	5,391 Added 3.99%	140,351 $2.33 Million
Q4 2018 Feb 14, 2019	BUY	$16.51 - $51.33 $198,813 - $618,115	12,042 Added 9.8%	134,960 $2.59 Million
Q3 2018 Nov 13, 2018	BUY	$43.15 - $67.97 $3.45 Million - $5.43 Million	79,918 Added 185.86%	122,918 $6.43 Million
Q2 2018 Aug 08, 2018	BUY	$35.06 - $51.17 $494,346 - $721,497	14,100 Added 48.79%	43,000 $1.87 Million
Q1 2018 May 07, 2018	BUY	$19.05 - $41.76 $272,415 - $597,168	14,300 Added 97.95%	28,900 $1.07 Million
Q3 2017 Nov 13, 2017	BUY	$12.53 - $27.12 $182,938 - $395,952	14,600	14,600 $364,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account